封面
市場調查報告書
商品編碼
1917724

電子處方箋市場-2026年至2031年預測

E-Prescribing Market - Forecast from 2026 to 2031

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

電子處方箋市場預計將從 2025 年的 23.81 億美元成長到 2031 年的 84.49 億美元,複合年成長率為 23.5%。

電子處方箋市場是全球醫療保健領域數位轉型的重要組成部分。電子處方箋是指醫療服務提供者向藥房電子生成和傳輸處方箋的過程,這標誌著與傳統紙質處方方式的根本性轉變。該技術無需手寫處方箋,簡化了藥物管理流程,並可直接與藥房系統整合。提案其普及的核心價值在於:透過減少因字跡不清或劑量錯誤導致的用藥錯誤來提高病患安全;提高臨床運作效率;並促進病患更好地堅持用藥並有效管理藥物。隨著全球醫療保健系統將數位化列為優先事項,對整合式電子配藥解決方案的需求正在經歷顯著且持續的成長。

市場擴張的關鍵促進因素是電子健康記錄 (EHR) 的加速普及和更廣泛的醫療保健數位化舉措。電子配藥功能正日益成為綜合 EHR 平台的核心模組,這為醫療機構採用這些整合系統提供了自然的途徑。許多地區的政府政策和獎勵計劃正在積極推廣使用經認證的 EHR 技術,包括電子配藥功能,以提高醫療保健品質和互通性。這種監管和製度促進因素,加上醫療保健產業對互聯互通和數據驅動醫療的策略關注,正為門診和住院環境中電子處方箋的普及提供強勁動力。

此外,電子配藥解決方案的經濟和營運效益正在推動其普及。這些系統透過消除列印、管理和實體傳輸紙處方箋等人工操作,切實降低了成本並提高了營運效率。它們減輕了臨床人員的行政負擔,最大限度地縮短了藥房與患者的接觸時間,並加快了處方箋配藥流程。對於利潤空間緊張的醫療機構而言,減少錯誤、提高員工效率和增強病患回應速度所帶來的投資回報,為實施這些系統提供了強而有力的經濟理由。反過來,這些效率的提高又促進了由藥房支持的、更順暢且不易出錯的藥品供應鏈的形成。

同時,技術進步也在推動市場發展。雲端平台的演進使得先進的電子配藥解決方案更易於取得和擴展,這對缺乏大規模IT基礎設施的小規模診所尤其有利。與行動應用程式的整合提高了醫療服務提供者的便利性,並透過諸如向智慧型手機發送電子處方箋等功能增強了病人參與。現代電子配藥系統提供即時療效驗證、藥物交互作用警報和處方箋核對工具等高級功能,超越了簡單的電子傳輸,發展成為能夠提高配藥準確性和成本效益的主動決策支援系統。

從地理上看,北美已成為電子配藥解決方案的領先市場。這一主導地位源於多種因素的共同作用,包括成熟的醫療資訊IT基礎設施、電子健康記錄(EHR)的早期廣泛應用,以及透過立法和標準積極推動數位化處方箋的法規環境。醫療服務提供者和患者對電子配藥益處的高度認知、主要供應商的存在以及完善的健康資訊網路,共同促成了電子配藥解決方案在標準臨床實踐中的廣泛應用。北美市場的特點是配藥師和藥房之間高度互聯互通,這得益於確保互通性和安全資料交換的全國性網路。

競爭格局由幾個關鍵參與企業組成。領先的電子病歷 (EHR) 平台供應商,例如 Epic Systems Corporation 和 Cerner Corporation,利用其在醫療系統 IT 領域的強大地位,提供深度整合的電子配藥模組,作為綜合臨床套件的一部分。同時,還有一些專注於先進藥物歷史管理服務、處方藥監測計劃 (PDMP) 整合以及安全的醫藥中心通訊平台的最佳組合專業電子配藥解決方案提供商,例如 DrFirst Inc.。該生態系統的關鍵底層技術是醫療資訊網路,以 Surescripts 為代表,它經營一個連接配藥機構、藥房和支付方的全國性基礎設施,從而實現大規模的安全資料交換。

該領域的主要企業持續致力於提升互通性、擴展臨床決策支援功能,並與更廣泛的醫療保健資料來源進行整合。其策略方向包括從基礎處方箋工具轉型為智慧藥物管理平台。此發展趨勢涵蓋更全面的患者用藥史、簡化事前核准流程,以及在診療現場提供可操作的洞察。因此,市場發展軌跡將取決於其從單純的效率工具向現代數位醫療框架內互聯、安全、高效藥物管理的關鍵組成部分的演變。

本報告的主要優勢

  • 深入分析:獲取主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業及其他細分市場。
  • 競爭格局:了解全球主要參與企業的策略舉措,並了解透過正確的策略進入市場的潛力。
  • 市場促進因素與未來趨勢:探討影響市場的動態因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議:利用這些見解,在快速變化的環境中製定策略決策,發展新的商業機會和收入來源。
  • 受眾廣泛:對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

以下是一些公司如何使用這份報告的範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍:

  • 2021-2025年實際數據,2026-2031年預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區分類的收入和預測評估,包括國家/地區
  • 公司概況(策略、產品、財務資訊、重大發展等)

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 電子處方箋市場(依產品分類)

  • 介紹
  • 解決方案
  • 服務

6. 按交付方式分類的電子處方箋市場

  • 介紹
  • 基於網路的
  • 本地部署
  • 基於雲端的

第7章 電子處方箋市場(依最終使用者分類)

  • 介紹
  • 醫院
  • 診所
  • 藥局

第8章:各地區的電子處方箋市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第10章:公司簡介

  • Cerner Corporation
  • Veradigm LLC(前身為 AllScripts)
  • athenahealth
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Practice Fusion, Inc(acquired by Veradigm LLC)
  • Surescripts LLC
  • DrFirst
  • Medical Information Technology, Inc.(MEDITECH)

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061615677

The E-Prescribing market , with a 23.5% CAGR, is projected to increase from USD 2.381 billion in 2025 to USD 8.449 billion in 2031.

The e-prescribing market is a critical component of the ongoing digital transformation within the global healthcare sector. E-prescribing, the process of electronically generating and transmitting prescription orders from healthcare providers to pharmacies, represents a fundamental shift from traditional paper-based methods. This technology eliminates handwritten scripts, streamlines the medication management workflow, and directly interfaces with pharmacy systems. The core value proposition driving adoption centers on enhancing patient safety by reducing medication errors related to illegibility or incorrect dosing, improving operational efficiency within clinical practices, and facilitating better medication adherence and management. As healthcare systems worldwide prioritize digitization, the demand for integrated e-prescribing solutions is experiencing significant and sustained growth.

A primary catalyst for market expansion is the accelerating adoption of Electronic Health Records (EHRs) and broader healthcare digitalization initiatives. E-prescribing functionality is increasingly embedded as a core module within comprehensive EHR platforms, creating a natural pathway for adoption as providers implement these integrated systems. Government policies and incentive programs in many regions actively promote the use of certified EHR technology, which includes e-prescribing capabilities, to improve care quality and interoperability. This regulatory and institutional push, combined with the healthcare industry's strategic focus on connectivity and data-driven care, creates a powerful driver for e-prescribing implementation across ambulatory and inpatient settings.

Furthermore, the compelling economic and operational benefits of e-prescribing solutions fuel their adoption. These systems deliver tangible cost savings and workflow efficiencies by eliminating manual processes associated with paper prescriptions, such as printing, handling, and physical transmittal. They reduce administrative burdens on clinical staff, minimize time spent on pharmacy callbacks for clarification, and accelerate the prescription fulfillment process. For healthcare organizations operating under margin pressures, the return on investment from reduced errors, improved staff productivity, and enhanced patient throughput provides a strong financial rationale for deployment. The efficiency gains extend to pharmacies, fostering a more seamless and error-resistant medication supply chain.

Concurrent technological advancements are also propelling the market forward. The evolution of cloud-based platforms has made sophisticated e-prescribing solutions more accessible and scalable, particularly for smaller practices without extensive IT infrastructure. Integration with mobile applications enhances accessibility for providers and can improve patient engagement through features like electronic prescription delivery to smartphones. Modern e-prescribing systems offer advanced functionalities such as real-time benefit checks, drug interaction alerts, and formulary compliance tools, moving beyond simple electronic transmission to become active decision-support systems that improve prescribing accuracy and cost-effectiveness.

Geographically, North America is established as the leading market for e-prescribing solutions. This leadership position is attributed to a confluence of factors: a mature healthcare IT infrastructure, early and widespread EHR adoption, and a regulatory environment that has actively encouraged digital prescribing through legislation and standards. High awareness of the benefits among both providers and patients, coupled with the presence of major technology vendors and well-established health information networks, has cemented widespread integration into standard clinical practice. The region's market is characterized by a high degree of connectivity between prescribers and pharmacies, facilitated by national networks that ensure interoperability and secure data exchange.

The competitive landscape is comprised of several key player segments. Major EHR platform vendors, such as Epic Systems Corporation and Cerner Corporation, offer deeply integrated e-prescribing modules as part of their comprehensive clinical suites, leveraging their entrenched position in health system IT. Alongside these are best-of-breed and specialized e-prescribing solution providers, like DrFirst Inc., which focus on advanced medication history services, prescription drug monitoring program (PDMP) integration, and secure provider-pharmacy communication platforms. A critical enabler in the ecosystem is the health information network, exemplified by Surescripts, which operates the national infrastructure connecting prescribers, pharmacies, and payers to facilitate secure data exchange at scale.

Leading companies in the space continue to focus on enhancing interoperability, expanding clinical decision support, and integrating with a wider array of healthcare data sources. The strategic direction involves moving from a foundational prescription routing tool to an intelligent medication management platform. This evolution includes incorporating more comprehensive patient medication histories, streamlining prior authorization processes, and providing actionable analytics at the point of care. The market's trajectory is thus defined by its progression from a discrete efficiency tool to an indispensable component of connected, safe, and efficient medication management within modern digital healthcare frameworks.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

E-Prescribing Market Segmentation

  • By Product
  • Solutions
  • Services
  • By Delivery Mode
  • Web-based
  • On-premise
  • Cloud-based
  • By End-User
  • Hospitals
  • Physician Offices
  • Pharmacies
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. E-PRESCRIBING MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Solutions
  • 5.3. Services

6. E-PRESCRIBING MARKET BY DELIVERY MODE

  • 6.1. Introduction
  • 6.2. Web-based
  • 6.3. On-premise
  • 6.4. Cloud-based

7. E-PRESCRIBING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Physician Offices
  • 7.4. Pharmacies

8. E-PRESCRIBING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Cerner Corporation
  • 10.2. Veradigm LLC (Formerly AllScripts)
  • 10.3. athenahealth
  • 10.4. NextGen Healthcare, Inc.
  • 10.5. McKesson Corporation
  • 10.6. Practice Fusion, Inc (acquired by Veradigm LLC)
  • 10.7. Surescripts LLC
  • 10.8. DrFirst
  • 10.9. Medical Information Technology, Inc. (MEDITECH)

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations